rs10998205

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001080449.3(DNA2):​c.357G>A​(p.Leu119Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 1,610,440 control chromosomes in the GnomAD database, including 10,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 945 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9613 hom. )

Consequence

DNA2
NM_001080449.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.36

Publications

16 publications found
Variant links:
Genes affected
DNA2 (HGNC:2939): (DNA replication helicase/nuclease 2) This gene encodes a member of the DNA2/NAM7 helicase family. The encoded protein is a conserved helicase/nuclease involved in the maintenance of mitochondrial and nuclear DNA stability. Mutations in this gene are associated with autosomal dominant progressive external ophthalmoplegia-6 (PEOA6) and Seckel syndrome 8. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
DNA2 Gene-Disease associations (from GenCC):
  • mitochondrial DNA deletion syndrome with progressive myopathy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • Seckel syndrome 8
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-68468207-C-T is Benign according to our data. Variant chr10-68468207-C-T is described in ClinVar as Benign. ClinVar VariationId is 257345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNA2NM_001080449.3 linkc.357G>A p.Leu119Leu synonymous_variant Exon 3 of 21 ENST00000358410.8 NP_001073918.2
DNA2XM_006717680.3 linkc.447G>A p.Leu149Leu synonymous_variant Exon 4 of 22 XP_006717743.1
DNA2NR_102264.2 linkn.446G>A non_coding_transcript_exon_variant Exon 4 of 22
DNA2XM_017015799.1 linkc.-170G>A 5_prime_UTR_variant Exon 1 of 18 XP_016871288.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNA2ENST00000358410.8 linkc.357G>A p.Leu119Leu synonymous_variant Exon 3 of 21 1 NM_001080449.3 ENSP00000351185.3
DNA2ENST00000551118.6 linkc.357G>A p.Leu119Leu synonymous_variant Exon 3 of 17 5 ENSP00000450393.3

Frequencies

GnomAD3 genomes
AF:
0.0922
AC:
14014
AN:
152022
Hom.:
940
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0309
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.0914
Gnomad EAS
AF:
0.139
Gnomad SAS
AF:
0.246
Gnomad FIN
AF:
0.145
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0894
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.136
AC:
33500
AN:
246824
AF XY:
0.136
show subpopulations
Gnomad AFR exome
AF:
0.0291
Gnomad AMR exome
AF:
0.260
Gnomad ASJ exome
AF:
0.0949
Gnomad EAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.0881
Gnomad OTH exome
AF:
0.121
GnomAD4 exome
AF:
0.102
AC:
148304
AN:
1458300
Hom.:
9613
Cov.:
31
AF XY:
0.106
AC XY:
76692
AN XY:
725208
show subpopulations
African (AFR)
AF:
0.0263
AC:
878
AN:
33426
American (AMR)
AF:
0.251
AC:
11079
AN:
44210
Ashkenazi Jewish (ASJ)
AF:
0.0910
AC:
2371
AN:
26062
East Asian (EAS)
AF:
0.127
AC:
5025
AN:
39602
South Asian (SAS)
AF:
0.239
AC:
20303
AN:
85104
European-Finnish (FIN)
AF:
0.139
AC:
7381
AN:
53234
Middle Eastern (MID)
AF:
0.115
AC:
661
AN:
5760
European-Non Finnish (NFE)
AF:
0.0852
AC:
94590
AN:
1110646
Other (OTH)
AF:
0.0998
AC:
6016
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
5732
11464
17197
22929
28661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3634
7268
10902
14536
18170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0923
AC:
14039
AN:
152140
Hom.:
945
Cov.:
32
AF XY:
0.0975
AC XY:
7247
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0310
AC:
1288
AN:
41544
American (AMR)
AF:
0.171
AC:
2608
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0914
AC:
317
AN:
3468
East Asian (EAS)
AF:
0.140
AC:
723
AN:
5174
South Asian (SAS)
AF:
0.246
AC:
1189
AN:
4828
European-Finnish (FIN)
AF:
0.145
AC:
1533
AN:
10550
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0894
AC:
6076
AN:
67994
Other (OTH)
AF:
0.114
AC:
240
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
627
1255
1882
2510
3137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0860
Hom.:
331
Bravo
AF:
0.0897
Asia WGS
AF:
0.182
AC:
634
AN:
3478
EpiCase
AF:
0.0850
EpiControl
AF:
0.0890

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.24
DANN
Benign
0.53
PhyloP100
-4.4
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10998205; hg19: chr10-70227964; COSMIC: COSV64427426; API